News

Part 1 of the Dress to Impress Summer Update 2025 is here, and it brings a new layout, new clothes, accessories, and plenty more. This page lists everything ...
The “Martha Stewart Aesthetic” is all over my Instagram feed. So I wasn’t totally surprised to see it mentioned in Pinterest’s 2025 Summer Trend Report earlier this month.
Crypto Exchange Kraken Unveils ‘Krak,’ Its New All-in-One Global Money App The Krak app allows users to instantly transact across borders for almost no cost, while earning competitive rewards ...
In this article, we will take a look at the Top 15 Stock Picks for an Early Retirement Portfolio.
Kraft Heinz says it will stop using artificial food dyes by 2027, replacing them with natural versions or taking other steps, amid pressure from Robert F. Kennedy Jr.
Widespread Use: The hosts of The Times’s “ Hard Fork ” podcast on how everyone seems to be using A.I. — for everything.
Opponents say that the plan to sell public lands isn't about fixing the affordable housing crisis. It's about reshaping land ownership in the West.
A new survey from the NBC Decision Desk Poll, powered by Survey Monkey, showed that 64 percent of Americans disapprove of the use of state funds for this weekend’s military parade.
Alex Bregman's return to the Red Sox isn't imminent, but he's hopeful to be back in the lineup in the next few weeks.
Governors aren't on the same page about the National Guard for "No Kings" protests. Georgia Gov. Brian Kemp warned against violence in social media post.
German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.